Comparing Different Startegies of Positive Pressure Ventilation in Children
- Conditions
- Ventilation Therapy; Complications
- Interventions
- Other: volume controlled ventilationOther: pressure controlled ventilationOther: pressure controlled volume grantanteed ventilation
- Registration Number
- NCT06612125
- Lead Sponsor
- Beni-Suef University
- Brief Summary
The most basic modes of mechanical ventilation are volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). VCV guarantees a target volume of ventilation using a constant flow, but may lead to high peak airway pressure (Ppeak) during the gas insufflation . In PCV mode, on the other hand,
- Detailed Description
The laryngeal mask airway (LMA) provides a useful alternative for airway management during general anaesthesia. Inflation of the LMA cuff produces a low-pressure seal around the larynx, enabling positive pressure ventilation (PPV). The use of LMA as an airway management technique is common in the pediatric anesthesia because of its less irritating effect on the airways due to its location in the upper larynx. Now, the use of laryngeal mask instead of tracheal intubation for airway management has been achieved in day surgery, therefore, how to perform a respiratory management with a laryngeal mask is particularly important. In addition, mechanical ventilation is also a commonly used method of airway management in clinical practice. the ventilator will deliver a constant pressure by decelerating the flow. However, the ventilation volume varies according to the patient's respiratory mechanics . Pressure-controlled ventilation-volume guaranteed (PCV-VG) combines the advantages of both VCV and PCV, which delivers a stable ventilation volume using a decelerating flow pattern.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 78
- age between 1 and 5 years.
- patient scheduled for laparoscopic inguinal hernia repair.
- American Society of Anesthesiologists classification of physical status of I-II.
- cardiopulmonary disease.
- severe hepatorenal dysfunction.
- history of upper respiratory tract infection 2 weeks before the operation.
- overweight [more than 20% of standard body weight].
- neuromuscular disease.
- anticipated difficult airway.
- hiatus hernia or gastroesophageal reflux disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description vCV group volume controlled ventilation Pediatric patients in the PCV group(n=30) received pressure-controlled ventilation. The initial parameters will be as follows: the peak inspiratory pressure (PIP) will set to provide a tidal volume of 7 ml/kg , respiratory rate will be 16 breaths/min, inspiratory to expiratory ratio was 1:2 with an upper limit of PIP of 20 cm H2O. PCV group pressure controlled ventilation Pediatric patients in the PCV group(n=30) received pressure-controlled ventilation. The initial parameters will be as follows: the peak inspiratory pressure (PIP) will set to provide a tidal volume of 7 ml/kg , respiratory rate will be 16 breaths/min, inspiratory to expiratory ratio was 1:2 with an upper limit of PIP of 20 cm H2O. PCV-VG group pressure controlled volume grantanteed ventilation Pediatric patients in the PCV-VG group (n=30)will be conducted with pressure-controlled volume-guaranteed ventilation, target tidal volume will set at 7 mL/kg, with a respiratory rate of 16 breaths/min and a respiratory ratio of 1:2.
- Primary Outcome Measures
Name Time Method (PIP) within one hour peak inspiratory pressure
Pplat within one hour plateau airway pressure
(Cdyn) within one hour pulmonary dynamic compliance
(RAW within one hour airway resistance
VT within one hour exhaled tidal volume
EtCO2 within one hour end-expiratory carbon dioxide
Vd/VT within one hour physiologic dead space over tidal volume
- Secondary Outcome Measures
Name Time Method (MAP) within one hour mean arterial pressure
(HR) within one hour heart rate
postoperative respiratory adverse events within 24 hour cough, hoarseness, sore throat, hypoxemia, laryngospasm, bronchospasm.
Trial Locations
- Locations (1)
Benisuef university hospital
🇪🇬Benisuef, Egypt